Skip to main content

Table 1 The relationship between miR-126-3p expression and clinicopathological characteristics in human HCC patients

From: MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2

Variables All patients miR-126-3p expression Pvalue
  (n = 70) Low* High*  
Age (years)     
≤55 24 12 12 1
>55 46 23 23  
Gender     
Male 62 31 31 1
Female 8 4 4  
Size of tumor (cm)     
≤5 30 12 18 0.147
>5 40 23 17  
Number of tumor     
Single 54 25 29 0.255
Multiple 16 10 6  
Portal vein invasion     
Negative 46 22 24 0.615
Positive 24 13 11  
TNM staging     
I, II 37 15 23 0.094
III 33 20 13  
Grade     
Well + Moderate 61 29 32 0.284
Poor 9 6 3  
AFP (ng/ml)     
≤400 39 16 23 0.092
>400 31 19 12  
  1. *The median expression level was used as the cut-off. Low expression of miR-126-3p in 35 patients was classified as values below the 50th percentile. High miR-126-3p expression in 35 patients was classified as values at or above the 50th percentile.
  2. For analysis of correlation between miR-126-3p expressions and clinical features, chi-square tests were used. Results were considered statistically significant at P <0.05.